Morgan Stanley Tekla Life Sciences Investors Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HQL
# of Institutions
77Shares Held
9.31MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$46.3 Million1.1% of portfolio
-
Penserra Capital Management LLC Orinda, CA776KShares$10.5 Million0.25% of portfolio
-
Karpus Management, Inc. Pittsford, NY469KShares$6.33 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.63 Million0.14% of portfolio
-
Needham Investment Management LLC New York, NY353KShares$4.76 Million0.43% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...